We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+16.93%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$2.62B
AUM Growth
+$228M
Cap. Flow
-$80.2M
Cap. Flow %
-3.06%
Top 10 Hldgs %
60.62%
Holding
146
New
15
Increased
46
Reduced
40
Closed
14

Top Buys

Rank Stock Value
1
STNG icon
Scorpio Tankers
STNG
+$45.3M
2
MU icon
Micron Technology
MU
+$35.2M
3
CCJ icon
Cameco
CCJ
+$28.2M
4
ZTO icon
ZTO Express
ZTO
+$23.4M
5
PBR icon
Petrobras
PBR
+$17.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.06%
2 Industrials 20.17%
3 Technology 17.4%
4 Healthcare 12.65%
5 Energy 11.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACIU icon
76
AC Immune
ACIU
$232M
$2.21M 0.08%
1,082,462
+23,000
+2% +$59.3K
AMAT icon
77
Applied Materials
AMAT
$415B
$2.11M 0.08%
21,644
PRDS
78
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$2.05M 0.08%
1,215,967
ALT icon
79
Altimmune
ALT
$593M
$1.95M 0.07%
118,730
WDC icon
80
Western Digital
WDC
$151B
$1.89M 0.07%
79,364
SRPT icon
81
Sarepta Therapeutics
SRPT
$1.81B
$1.85M 0.07%
+14,248
New +$1.65M
OMIC
82
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$1.77M 0.07%
29,369
BPMC
83
DELISTED
Blueprint Medicines
BPMC
$1.75M 0.07%
39,842
+6,980
+21% +$335K
TKNO icon
84
Alpha Teknova
TKNO
$361M
$1.74M 0.07%
309,178
-28,213
-8% -$125K
MRSN
85
DELISTED
Mersana Therapeutics
MRSN
$1.7M 0.06%
11,612
ALEC icon
86
Alector
ALEC
$189M
$1.68M 0.06%
181,689
+35,849
+25% +$313K
TAL icon
87
TAL Education Group
TAL
$6.93B
$1.6M 0.06%
226,309
YMM icon
88
Full Truck Alliance
YMM
$10.1B
$1.59M 0.06%
199,091
BCRX icon
89
BioCryst Pharmaceuticals
BCRX
$2.51B
$1.55M 0.06%
134,989
-86,710
-39% -$1.08M
DNLI icon
90
Denali Therapeutics
DNLI
$4B
$1.54M 0.06%
55,341
+4,370
+9% +$130K
SWKS icon
91
Skyworks Solutions
SWKS
$10.4B
$1.54M 0.06%
16,880
-9,577
-36% -$858K
PYPL icon
92
PayPal
PYPL
$50.5B
$1.49M 0.06%
20,870
ASMB icon
93
Assembly Biosciences
ASMB
$530M
$1.42M 0.05%
91,231
-29,630
-25% -$507K
PVLA
94
Palvella Therapeutics
PVLA
$2.19B
$1.27M 0.05%
15,260
BKI
95
DELISTED
Black Knight, Inc. Common Stock
BKI
$1.27M 0.05%
+20,512
New +$1.25M
CTMX icon
96
CytomX Therapeutics
CTMX
$750M
$1.02M 0.04%
635,798
-593,747
-48% -$878K
EBAY icon
97
eBay
EBAY
$47.9B
$940K 0.04%
22,679
FWONK icon
98
Liberty Media Series C
FWONK
$25.8B
$915K 0.03%
15,825
ELUT icon
99
Elutia
ELUT
$36M
$800K 0.03%
188,181
RYAAY icon
100
Ryanair
RYAAY
$30.9B
$748K 0.03%
25,000
+12,500
+100% +$355K

Similar funds

Platinum Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Platinum Investment Management held 146 positions worth $2.62B, up 9.5% from $2.4B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Platinum Investment Management withdrew a net $80.2M in Q4 2022, closing 14 positions and reducing 40 holdings. Its most notable exit was BTRS Holdings Inc. Class 1 Common Stock, an estimated $27.7M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.

Against the trend, Platinum Investment Management opened a new position in Scorpio Tankers worth $48.8M.

  • Platinum Investment Management's largest Q4 2022 buy was Scorpio Tankers: 907,421 shares worth $48.8M.
  • Platinum Investment Management added most to Micron Technology in Q4 2022, an estimated $35.2M increase.
  • Platinum Investment Management's biggest Q4 2022 reduction was The Mosaic Company, cutting an estimated $75.8M.
  • Platinum Investment Management fully exited BTRS Holdings Inc. Class 1 Common Stock in Q4 2022, selling an estimated $27.7M.
  • Platinum Investment Management's ten largest holdings make up 61% of its $2.62B portfolio in Q4 2022.
  • Platinum Investment Management opened 15 new positions and closed 14 in Q4 2022.
  • Platinum Investment Management's portfolio value rose 9.5% quarter-over-quarter to $2.62B.

Based on Platinum Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.